Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 33 news outlets
twitter: 11 X users

patent: 1 patent
facebook: 1 Facebook page

Readers on

mendeley: 44 Mendeley

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 53,294 followers.

From one of our former COMET trainees Dr. Ara Nazarian and co-authors in @PNASNews evaluating the musculoskeletal phenotypes in different treatment groups of genetically modified G608G progeria mice. Learn more- https://t.co/s9mhuDGFoX

#NIAMSResearch @BIDMCHealth @harvardmed: “Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups” https://t.co/xaY9kM2pAy Full access requires subscription or payment…

RT @NazarianLab: Congrats to Belen Cubria,@sebsuarezmd, @LamoniSnicket, @NIHDirector & coauthors on our @PNASNews paper on phenotypic chang…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.